|
Bagnall RD, Waseem N, Green PM, Giannelli F, 2002. Recurrent inversion breaking intron 1 of the factor VIII gene is a frequent cause of severe hemophilia A. Blood 99:168-74. Castaldo G, Nardiello P, Bellitti F, Santamaria R, Rocino A, Coppola A, di Minno G, Salvatore F, 2003. Haemophilia B: from molecular diagnosis to gene therapy. Clin Chem Lab Med 41:445-51. Drayna D, White R, 1985. The genetic linkage map of the human X chromosome. Science 230:753-8. Erfle V, Hehlmann R, Mellert W, Kruger G, Seifried E, Heimpel H, Rasokat H, Lechler E, Holzer E, Hellstern P, et al., 1985. Prevalence of antibodies to HTLV-III in AIDS risk groups in West Germany. Cancer Res 45:4627s-4629s. Francis RB, Jr., Kasper CK, 1983. Reproduction in hemophilia. Jama 250:3192-5. Gitschier J, Wood WI, Goralka TM, Wion KL, Chen EY, Eaton DH, Vehar GA, Capon DJ, Lawn RM, 1984. Characterization of the human factor VIII gene. Nature 312:326-30. Goodeve AC, 1998. Advances in carrier detection in haemophilia. Haemophilia 4:358-64. Huber CG, Oefner PJ, Bonn GK, 1993. High-resolution liquid chromatography of oligonucleotides on nonporous alkylated styrene-divinylbenzene copolymers. Anal Biochem 212:351-8. Ingerslev J, Schwartz M, Lamm LU, Kruse TA, Bukh A, Stenbjerg S, 1989. Female haemophilia A in a family with seeming extreme bidirectional lyonization tendency: abnormal premature X-chromosome inactivation? Clin Genet 35:41-8. Ivaskevicius V, Jurgutis R, Rost S, Muller A, Schmitt C, Wulff K, Herrmann FH, Muller CR, Schwaab R, Oldenburg J, 2001. Lithuanian haemophilia A and B registry comprising phenotypic and genotypic data. Br J Haematol 112:1062-70. Jones AC, Austin J, Hansen N, Hoogendoorn B, Oefner PJ, Cheadle JP, O''Donovan MC, 1999. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clin Chem 45:1133-40. Kemball-Cook G, Tuddenham EG, Wacey AI, 1998. The factor VIII Structure and Mutation Resource Site: HAMSTeRS version 4. Nucleic Acids Res 26:216-9. Kraus EM, Brettler DB, 1988. Assessment of reproductive risks and intentions by mothers of children with hemophilia. Am J Med Genet 31:259-67. Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, Hamilton SR, Hampel H, Markowitz A, Klimstra D, Jhanwar S, Winawer S, Offit K, Luce MC, Kinzler KW, Vogelstein B, 1997. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 17:79-83. Lakich D, Kazazian HH, Jr., Antonarakis SE, Gitschier J, 1993. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A. Nat Genet 5:236-41. Leuer M, Oldenburg J, Lavergne JM, Ludwig M, Fregin A, Eigel A, Ljung R, Goodeve A, Peake I, Olek K, 2001. Somatic mosaicism in hemophilia A: a fairly common event. Am J Hum Genet 69:75-87. Liu Q, Nozari G, Sommer SS, 1998. Single-tube polymerase chain reaction for rapid diagnosis of the inversion hotspot of mutation in hemophilia A. Blood 92:1458-9. Liu Q, Sommer SS, 1998. Subcycling-PCR for multiplex long-distance amplification of regions with high and low GC content: application to the inversion hotspot in the factor VIII gene. Biotechniques 25:1022-8. Ljung R, Tedgard U, 2003. Genetic counseling of hemophilia carriers. Semin Thromb Hemost 29:31-6. Ljung RC, Sjorin E, 1999. Origin of mutation in sporadic cases of haemophilia A. Br J Haematol 106:870-4. O''Donovan MC, Oefner PJ, Roberts SC, Austin J, Hoogendoorn B, Guy C, Speight G, Upadhyaya M, Sommer SS, McGuffin P, 1998. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection. Genomics 52:44-9. Peake I, 1998. Genetic services available for counselling and prenatal diagnosis of haemophilia. Haemophilia 4 Suppl 2:24-5. Pittman DD, Alderman EM, Tomkinson KN, Wang JH, Giles AR, Kaufman RJ, 1993. Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII. Blood 81:2925-35. Rosendaal FR, Smit C, Briet E, 1991. Hemophilia treatment in historical perspective: a review of medical and social developments. Ann Hematol 62:5-15. Rosner F, 1969. Hemophilia in the Talmud and rabbinic writings. Ann Intern Med 70:833-7. Saenko EL, Ananyeva N, Kouiavskaia D, Schwinn H, Josic D, Shima M, Hauser CA, Pipe S, 2002. Molecular defects in coagulation Factor VIII and their impact on Factor VIII function. Vox Sang 83:89-96. Schwaab R, Brackmann HH, Meyer C, Seehafer J, Kirchgesser M, Haack A, Olek K, Tuddenham EG, Oldenburg J, 1995. Haemophilia A: mutation type determines risk of inhibitor formation. Thromb Haemost 74:1402-6. Sumita DR, Vainzof M, Campiotto S, Cerqueira AM, Canovas M, Otto PA, Passos-Bueno MR, Zatz M, 1998. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers. Am J Med Genet 80:356-61. Thompson AR, 2003. Structure and function of the factor VIII gene and protein. Semin Thromb Hemost 29:11-22. Tuddenham EG, Cooper DN, Gitschier J, Higuchi M, Hoyer LW, Yoshioka A, Peake IR, Schwaab R, Olek K, Kazazian HH, et al., 1991. Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene. Nucleic Acids Res 19:4821-33. Varekamp I, Suurmeijer T, Brocker-Vriends A, Rosendaal FR, 1992. Hemophilia and the use of genetic counseling and carrier testing within family networks. Birth Defects Orig Artic Ser 28:139-48. Varekamp I, Suurmeijer TP, Brocker-Vriends AH, van Dijck H, Smit C, Rosendaal FR, Briet E, 1990. Carrier testing and prenatal diagnosis for hemophilia: experiences and attitudes of 549 potential and obligate carriers. Am J Med Genet 37:147-54. Varekamp I, Suurmeijer TP, Rosendaal FR, Brocker-Vriends AH, 1993. The use of preventive health care services: carrier testing for the genetic disorder haemophilia. Soc Sci Med 37:639-48. Wollina K, Bowen DJ, Syrbe G, Zintl F, 1993. Female twins with severe Christmas disease (hemophilia B). Thromb Haemost 70:774-6. Xie YG, Zheng H, Leggo J, Scully MF, Lillicrap D, 2002. A founder factor VIII mutation, valine 2016 to alanine, in a population with an extraordinarily high prevalence of mild hemophilia A. Thromb Haemost 87:178-9.
|